Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Pfizer synthesizes novel ghrelin receptor antagonists/inverse agonists

Oct. 11, 2011

Trimel Pharmaceuticals provides update on phase II Vibro-Tactile Stimulation trial

Oct. 10, 2011

Victoza launched in China

Oct. 10, 2011

FDA approves Merck & Co.'s Juvisync

Oct. 10, 2011

Protalix Biotherapeutics patents novel cross-linked multimeric proteins for Gaucher's disease

Oct. 10, 2011

New cross-linked multimeric proteins for Fabry's disease claimed by Protalix Biotherapeutics

Oct. 7, 2011

BioCryst presents topline data from phase IIb BCX-4208 trial

Oct. 6, 2011

Novel sirtuin modulators prepared by Sirtris Pharmaceuticals

Oct. 6, 2011

Two phase III trials of LibiGel in female sexual dysfunction completed

Oct. 6, 2011

Neurocrine and Abbott reach second milestone in elagolix collaboration

Oct. 5, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...